Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Clascoterone
Topical Androgen Receptor Inhibitor | Acne & Hair Loss
Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take BPC-157 with Clascoterone?
Yes, BPC-157 and Clascoterone can generally be taken together. Both BPC-157 and Clascoterone promote collagen synthesis. Complementary mechanisms may enhance connective tissue repair and skin quality.
Is BPC-157 and Clascoterone safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between BPC-157 and Clascoterone?
Both BPC-157 and Clascoterone promote collagen synthesis. Complementary mechanisms may enhance connective tissue repair and skin quality. This assessment has 45% confidence and is inferred from pharmacological mechanism analysis.
How should I time BPC-157 and Clascoterone?
BPC-157 has a half-life of <30 minutes and Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.